Low density lipoprotein (LDL), atherosclerosis and antioxidants

被引:0
|
作者
Ryu B.H. [1 ]
机构
[1] Department of Food Science and Biotechnology, Kyungsung University
关键词
Antioxidant; Atherosclerosis; Low density lipoprotein (LDL);
D O I
10.1007/BF02942205
中图分类号
学科分类号
摘要
A crucial and causative role in the pathogenesis of atherosclerosis is believed to be the oxidative modification of low density lipoprotein (LDL). The oxidation of LDL involves released free radical driven lipid peroxidation. Several lines of evidence support the role of oxidized LDL in atherogenesis. Epidemiologic studies have demonstrated an association between an increased intake of dietary antioxidant vitamins, such as vitamin E and vitamin C and reduced morbidity and mortality from coronary artery diseases. It is thus hypothesized that dietary antioxidants may help prevent the development and progression of atherosclerosis. The oxidation of LDL has been shown to be reduced by antioxidants, and, in animal models, improved antioxidants may offer possibilities for the prevention of atherosclerosis. The results of several on going long randomized intervention trials will provide valuable information on the efficacy and safety of improved antioxidants in the prevention of atherosclerosis. This review a evaluates current literature involving antioxidants and vascular disease, with a particular focus on the potential mechanisms.
引用
收藏
页码:313 / 319
页数:6
相关论文
共 50 条
  • [31] LOW-DENSITY-LIPOPROTEIN (LDL) METABOLISM AND LDL RECEPTORS OF HUMAN PLACENTA
    ASADA, Y
    NOMURA, S
    HOTTA, R
    FURUHASHI, M
    ABE, M
    KATO, H
    KASUGAI, M
    MIZUTANI, S
    TOMODA, Y
    PLACENTAL PROTEIN HORMONES, 1988, 798 : 311 - 311
  • [32] LOW-DENSITY LIPOPROTEIN (LDL) RECEPTORS AND THE REGULATION OF SERUM LDL LEVELS
    VERMEER, BJ
    NETHERLANDS JOURNAL OF MEDICINE, 1985, 28 (02): : 52 - 58
  • [33] Low-density lipoprotein (LDL) oxidizability before and after LDL apheresis
    Donner, MG
    Parhofer, KG
    Richter, WO
    Schwandt, P
    METABOLISM-CLINICAL AND EXPERIMENTAL, 1999, 48 (07): : 881 - 886
  • [34] Modulation of base excision repair by low density lipoprotein, oxidized low density lipoprotein and antioxidants in mouse monocytes
    Chen, KH
    Srivastava, DK
    Singhal, RK
    Jacob, S
    Ahmed, AE
    Wilson, SH
    CARCINOGENESIS, 2000, 21 (05) : 1017 - 1022
  • [35] Vasocare™ therapy markedly reduces atherosclerosis in low density lipoprotein receptor deficient (LDL-R (-/-)) mice
    Picard, P
    Babaei, S
    Stewart, DJ
    Monge, JC
    FASEB JOURNAL, 1999, 13 (04): : A176 - A176
  • [36] THE LOW-DENSITY-LIPOPROTEIN AND LOW-DENSITY-LIPOPROTEIN RECEPTORS AND THEIR POSSIBLE IMPORTANCE IN THE PATHOGENESIS OF ATHEROSCLEROSIS
    DRESEL, HA
    FRIEDRICH, EA
    OTTO, I
    WALDHERR, R
    SCHETTLER, G
    ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1985, 35-2 (12A): : 1936 - 1940
  • [37] Atherosclerosis regression: Is low-density lipoprotein or high-density lipoprotein the answer?
    Nicholls S.J.
    Tuzcu E.M.
    Nissen S.E.
    Current Atherosclerosis Reports, 2007, 9 (4) : 266 - 273
  • [38] DIABETIC LOW-DENSITY-LIPOPROTEIN (LDL) APOPROTEIN-B IS MORE SUSCEPTIBLE TO OXIDATION AND ANTIOXIDANTS REDUCE SUSCEPTIBILITY
    GOWRI, MS
    ANDERSON, JW
    FASEB JOURNAL, 1995, 9 (03): : A574 - A574
  • [39] DIALYSIS MODALITY AND LOW-DENSITY-LIPOPROTEIN (LDL) PHENOTYPE AND LIPOPROTEIN PROFILE
    LEE, P
    ONEAL, D
    SIKARIS, K
    MURPHY, B
    BEST, J
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1994, 5 (03): : 496 - 496
  • [40] Platelet factor 4 inhibits the degradation of low density lipoprotein receptor dependent low density lipoprotein (LDL) degradation by retention of LDL on the cell surface
    Sachals, BS
    Higazi, AA
    Poncz, M
    Williams, KJ
    Kuo, A
    Shah, N
    Jarett, L
    Cines, DB
    TRANSFUSION, 2000, 40 (10) : 6S - 6S